1. Home
  2. PTLE vs BOLT Comparison

PTLE vs BOLT Comparison

Compare PTLE & BOLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTLE
  • BOLT
  • Stock Information
  • Founded
  • PTLE 2013
  • BOLT 2015
  • Country
  • PTLE Singapore
  • BOLT United States
  • Employees
  • PTLE N/A
  • BOLT N/A
  • Industry
  • PTLE Oil Refining/Marketing
  • BOLT Biotechnology: Pharmaceutical Preparations
  • Sector
  • PTLE Energy
  • BOLT Health Care
  • Exchange
  • PTLE Nasdaq
  • BOLT Nasdaq
  • Market Cap
  • PTLE 16.4M
  • BOLT 16.8M
  • IPO Year
  • PTLE 2024
  • BOLT 2021
  • Fundamental
  • Price
  • PTLE $1.40
  • BOLT $0.31
  • Analyst Decision
  • PTLE
  • BOLT Buy
  • Analyst Count
  • PTLE 0
  • BOLT 3
  • Target Price
  • PTLE N/A
  • BOLT $2.50
  • AVG Volume (30 Days)
  • PTLE 2.2M
  • BOLT 738.6K
  • Earning Date
  • PTLE 02-21-2025
  • BOLT 05-12-2025
  • Dividend Yield
  • PTLE N/A
  • BOLT N/A
  • EPS Growth
  • PTLE N/A
  • BOLT N/A
  • EPS
  • PTLE N/A
  • BOLT N/A
  • Revenue
  • PTLE $98,133,646.00
  • BOLT $3,638,000.00
  • Revenue This Year
  • PTLE N/A
  • BOLT N/A
  • Revenue Next Year
  • PTLE N/A
  • BOLT $64.44
  • P/E Ratio
  • PTLE N/A
  • BOLT N/A
  • Revenue Growth
  • PTLE N/A
  • BOLT N/A
  • 52 Week Low
  • PTLE $1.08
  • BOLT $0.28
  • 52 Week High
  • PTLE $15.78
  • BOLT $0.80
  • Technical
  • Relative Strength Index (RSI)
  • PTLE N/A
  • BOLT 40.60
  • Support Level
  • PTLE N/A
  • BOLT $0.28
  • Resistance Level
  • PTLE N/A
  • BOLT $0.32
  • Average True Range (ATR)
  • PTLE 0.00
  • BOLT 0.04
  • MACD
  • PTLE 0.00
  • BOLT -0.00
  • Stochastic Oscillator
  • PTLE 0.00
  • BOLT 13.54

About PTLE PTL LTD Ordinary Shares

PTL Ltd is a holding company. Through its subsidiaries, it is an established bunkering facilitator providing marine fuel logistics services for vessel refuelling, primarily serving the Asia Pacific market. As a bunker facilitator, the Group's services mainly involve facilitating with its suppliers to supply fuel for the use by the customers' vessels at various ports along their voyages in the Asia Pacific region; arranging vessel refuelling activities at competitive pricing to the customers; offering trade credit to the customers for vessel refuelling; handling unforeseeable circumstances faced by the customers and providing contingency solutions to the customers in a timely manner; and handling disputes, mainly in relation to quality and quantity issues on marine fuel, if any.

About BOLT Bolt Biotherapeutics Inc.

Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.

Share on Social Networks: